000 | 00717nas a2200265 i 4500 | ||
---|---|---|---|
001 | 300000594 | ||
003 | UVAL | ||
005 | 20240507115222.0 | ||
007 | ta | ||
008 | 010707c ner | p 0 0 0und d | ||
022 | _a13815660 | ||
040 |
_aDIBRA _cUVAL _beng _erda |
||
245 | 0 | 0 |
_aOdyssey / _cGlaxo Wellcome. |
264 | 3 | 1 |
_aAmsterdam : _bPMSI Bugamor BV, _c1995. |
310 | _aCuatrimestral | ||
650 | 0 | _aPUBLICACIONES SERIADAS. | |
650 | 0 | _aINVESTIGACION. | |
853 | 2 | 0 |
_B2 _Cr |
866 | 4 | 1 | _aVol. 3: No. 1-2; 1997 |
866 | 4 | 1 | _aVol. 6: No. 2; Año 2000 |
942 | _c3 | ||
999 |
_c87006 _d87006 |